Patent · US Expired

Modulating the efficiency of nucleic acid amplification reactions with 3' modified oligonucleotides

US6057134A · kind A · utility

38Cited by
3References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 7, 1996
Grant dateMay 2, 2000
Priority date
Expiry dateOct 7, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2537/143
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to modified oligonucleotide primers used to adjust the amplification efficiency of an abundant target without affecting the amplification of other targets in a DNA synthesis reaction. The invention may be used in PCR.TM. or any other primer dependent DNA transcription technology.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.